MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,765.36
-0.47%
NASDAQ 100
$30,725.81
-1.39%
DOW JONES
$51,232.00
+0.10%
NASDAQ Composite
$27,193.34
-1.25%
RUSSELL 2000
$2,775.70
-0.05%
CBOE VIX
$15.41
+2.19%
Sector Heatmap
Technology-1.79%
Financials+0.89%
Healthcare-0.39%
Consumer Cycl+0.31%
Consumer Staples+2.11%
Energy+2.97%
Industrials+0.33%
Materials+0.59%
Real Estate+0.69%
Utilities-0.19%
Comm Services+0.73%
RYTM — Rhythm Pharmaceuticals, Inc. Common Stock
NasdaqRhythm Pharmaceuticals, Inc. Common Stock
$89.64
+1.19(+1.35%)
- O
- 89.05
- H
- 90.94
- L
- 87.01
- V
- 943.82K
⏱️ End-of-day dataAs of Oct 8, 2026
RYTM — Latest News & Headlines
5 StoriesHere’s How Much You Would Have Made Owning Rhythm Pharmaceuticals Stock In The Last 5 Years - Benzinga
Here’s How Much You Would Have Made Owning Rhythm Pharmaceuticals Stock In The Last 5 Years Benzinga
RYTM Maintained by RBC Capital -- Price Target Raised to $159 - GuruFocus
RYTM Maintained by RBC Capital -- Price Target Raised to $159 GuruFocus
Why (RYTM) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Why (RYTM) Price Action Is Critical for Tactical Trading Stock Traders Daily
RBC raises target for Rhythm Pharmaceuticals stock to USD 159 - AD HOC NEWS
RBC raises target for Rhythm Pharmaceuticals stock to USD 159 AD HOC NEWS
RYTM Q2 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus, Shares Slip 2.89% - Revenue Recognition Risk - https://www.siam.in/
RYTM Q2 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus, Shares Slip 2.89% - Revenue Recognition Risk https://www.siam.in/